iCare TA01i Tonometer "The Original"
iCare TA01i is the first rebound tonometer introduced to the world by iCare. The original iCare tonometer is the right choice for a reliable basic device. The ease of use makes it an important instrument for general practitioners, optometrists, occupational health care, pharmacies and other medical personnel. It is handy in clinics for both adult and pediatric readings as well as in the field, i.e. in mass glaucoma screenings.
Requiring no drops or specialized training makes IOP measuring quick and easy for screening programs and humanitarian missions around the world. Since single-use probes are used for measurement, there is no risk of microbiological contamination.
Rebound tonometry eliminated the need for anesthetic drops that means reduced patient waiting times and lower costs. As a result, the patient flow can be kept dynamic even with massive screening programs.
The iCare TA01i tonometer provides accurate, objective intraocular pressure (IOP) readings of even the most demanding patients, such as children or dementia patients. With iCare TA01i, you can measure IOP when the patient is in a sitting or standing position.
The iCare TA01i is supremely durable and will last for years. It does not need calibration and thus, time-consuming maintenance. Deployment of the device requires only minimal training, which makes it suitable for use by a wide range of healthcare professionals from doctors to technicians. The iCare TA01i has an excellent quality-price ratio.
As all iCare’s tonometers, the TA01i’s working principle is based on the patented rebound technology, which eliminates corneal disruptions and patient discomfort. The exclusive rebound technology allows painless and hygienic IOP measurement without local anesthesia. There is no patient hesitation when the iCare tonometer is used on the second eye.
Click to find your local sales representative
Find a repClick to download the TA01i brochure
TA01i BrochureDownload the product manuals directly from the website
TA01i Manual
